Genenta Science S.p.A. (SAEN) stock
SAENNasdaqBiological Products, (No Diagnostic Substances)Also trades as GNTA
$0.68−0.04 (-5.28%)
Close on Nov 11, 2026Market cap $15.93MP/E –Yield –
Genenta Science S.p.A. EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
For fiscal 2025 it was -0.33 EUR. The highest annual figure on record is -0.33 EUR in fiscal 2025.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -0.33 EUR | – |
| FY2024 | Dec 31, 2024 | -0.49 EUR | – |
| FY2023 | Dec 31, 2023 | -0.64 EUR | – |
| FY2022 | Dec 31, 2022 | -0.47 EUR | – |
| FY2021 | Dec 31, 2021 | -0.37 EUR | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?